Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms

Journal of Urology

Volumn 184, Issue 2, 2010, Pages 506-511

  Morote, Juan ^a   Del Amo, Jokin ^c   Borque, Angel ^e   Ars, Elisabet ^b   Hernndez, Carlos ^g   Herranz, Felipe ^g   Arruza, Antonio ^f   Llarena, Roberto ^d   Planas, Jacques ^b   Viso, Mara J ^e   Palou, Joan ^a   Ravents, Carles X ^a   Tejedor, Diego ^c   Artieda, Marta ^c   Simn, Laureano ^c   Martnez, Antonio ^c   Rioja, Luis A ^e  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Fundacin Puigvert   (Spain)

^c Progenika Biopharma SA   (Spain)

^d HOSPITAL DE CRUCES   (Spain)

^e Hospital Miguel Servet   (Spain)

^f HOSPITAL TXAGORRITXU   (Spain)

^g HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

neoplasm recurrence; polymorphism; prognosis; prostate; prostatic neoplasms; single nucleotide

Indexed keywords

OLIGONUCLEOTIDE; PROSTATE SPECIFIC ANTIGEN; TOLL LIKE RECEPTOR 4;

ARTICLE; BIOCHEMISTRY; CANCER LOCALIZATION; FEMALE; FOLLOW UP; GENE TARGETING; GENOTYPE; GLEASON SCORE; HETEROZYGOTE; HUMAN; HYPOTHESIS; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 77955470820     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.03.144     Document Type: Article

References (30)

1. M.W. Kattan, T.M. Wheeler, and P.T. Scardino Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer J Clin Oncol 17 1999 1499
2. C. Pound, A. Partin, and M. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591
3. S. Shariat, P. Karakiewicz, and C. Roehrborn An updated catalog of prostate cancer predictive tools Cancer 113 2008 3075
4. T. Bismar, P. Humphrey, and R. Vollmer Information content of five nomograms for outcomes in prostate cancer Am J Clin Pathol 128 2007
5. M.J. Donovan, S. Hamann, and M. Clayton Systems pathology approach for the prediction of prostate cancer progression after radical prostatectomy J Clin Oncol 26 2008 3923
6. J.S. Witte Prostate cancer genomics: towards a new understanding Nat Rev Genet 10 2009 77
7. D.M. Peehl, M. Coram, and H. Khine The significance of monoamine oxidase-A expression in high grade prostate cancer J Urol 180 2008 2206
8. D. Tejedor, S. Castillo, and P. Mozas Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia Clin Chem 51 2005 1137
9. E. Steyerberg Clinical Prediction Models A Practical Approach to Development, Validation, and Updating 2009 Springer New York
10. S. Matsui Predicting survival outcomes using subsets of significant genes in prognostic marker studies with microarrays BMC Bioinformatics 7 2006 156
11. A Language and Environment for Statistical Computing R Development Core Team 2008 R Foundation for Statistical Computing Vienna, Austria
12. F. Harrel Regression Modeling Strategies 2001 Springer-Verlag New York
13. M.J. Pencina, R.B. D'Agostino Sr, and R.B. D'Agostino Jr Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157
14. S. Eggener, A. Vickers, and A. Serio Comparison of models to predict clinical failure after radical prostatectomy Cancer 115 2009 303
15. S. Shariat, J. Karam, and J. Walz Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers Clin Cancer Res 14 2008 3785
16. R.S. Svatek, C. Jeldres, and P.I. Karakiewicz Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence Prostate 69 2009 886
17. S. Zheng, J. Sun, and F. Wiklund Cumulative association of five genetic variants with prostate cancer N Engl J Med 358 2008 910
18. R. Nam, W. Zhang, and J. Trachtenberg Utility of incorporating genetic variants for the early detection of prostate cancer Clin Cancer Res 15 2009 1787
19. J. Walz, F.K. Chun, and E.A. Klein Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer J Urol 181 2009 601
20. A.J. Stephenson, P.T. Scardino, and J.A. Eastham Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Clin Oncol 23 2005 7005
21. M. Graefen, P.I. Karakiewicz, and I. Cagiannos Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer J Clin Oncol 20 2002 951
22. N. Suardi, C.R. Porter, and A.M. Reuther A nomogram predicting long-term biochemical recurrence after radical prostatectomy Cancer 112 2008 1254
23. P. Helo, A.M. Cronin, and D.C. Danila Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival Clin Chem 55 2009 765
24. R. Nam, W. Zhang, and L. Klotz Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy Clin Cancer Res 12 2006 6452
25. S. Nowell, D. Ratnasinghe, and C. Ambrosone Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians Cancer Epidemiol Biomarkers Prev 13 2004 270
26. R. Raftogianis, T. Wood, and D. Otterness Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype Biochem Biophys Res Commun 239 1997 298
27. Y. Chen, E. Giovannucci, and R. Lazarus Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer Cancer Res 65 2005 11771
28. S. Zheng, K. Augustsson-Blter, and B. Chang Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the Cancer Prostate in Sweden Study Cancer Res 64 2004 2918
29. I. Cheng, S. Plummer, and G. Casey Toll-like receptor 4 genetic variation and advanced prostate cancer risk Cancer Epidemiol Biomarkers Prev 16 2007 352
30. I. Thompson, C. Tangen, and J. Paradelo Adjuvant radiotherapy for pathological t3n0m0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial J Urol 181 2009 965